References
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2023 [Mar 27, 2023]. Available from: https://covid19.who.int/table
- Wong A, Zoller C, Fouda A, et al. Are we past the COVID-19 pandemic? Insights from Singapore. Health Policy Technol. 2023;100779. doi: 10.1016/j.hlpt.2023.100779
- Statista. Share of population vaccinated against COVID-19 in Singapore as of Nov 22, 2022 2023 [updated May 22, 2023;August 22, 2023]. Available from: https://www.statista.com/statistics/1223524/singapore-covid-19-vaccines-administered/#:~:text=As%20of%20November%2022%2C%202022,being%20within%20the%20past%20year.
- Yu B, Li Q, Chen J, et al. The impact of COVID-19 vaccination campaign in Hong Kong SAR China and Singapore. Infect Dis Model. 2023;8(1):101–106. doi: 10.1016/j.idm.2022.12.004
- Lim V Singapore’s COVID-19 wave past its peak, cases fall to 3,000 per day: ong ye kung 2023 [updated May 9, 2023;August 22, 2023]. Available from: https://www.channelnewsasia.com/singapore/singapore-covid-19-wave-peaked-vaccinations-myocarditis-ong-ye-kung-parliament-may-9-3474566
- Grewal R, Nguyen L, Buchan SA, et al. Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nat Commun. 2023;14(1):1273.
- Collie S, Nayager J, Bamford L, et al. Effectiveness and durability of the BNT162b2 vaccine against omicron sublineages in South Africa. N Engl J Med. 2022;387(14):1332–1333.
- Kirsebom FC, Andrews N, Stowe J, et al. Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA. 4 and BA. 5 in England. The Lancet Regional Health–Europe. 2022 Dec 1;23.
- Tan CY, Chiew CJ, Pang D, et al. Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study. Lancet Infect Dis. 2023;23(12):1343–1348.
- Rosenblum HG, Wallace M, Godfrey M, et al. Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines — United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 [Oct 2022];71(45):1436–1441. doi: 10.15585/mmwr.mm7145a2
- Pung R, Kong XP, Cui L, et al. Severity of SARS-CoV-2 omicron XBB subvariants in Singapore. Lancet Reg Health West Pac. 2023;37:100849. doi: 10.1016/j.lanwpc.2023.100849
- Krammer F, Ellebedy AH. Variant-adapted COVID-19 booster vaccines. Science. 2023;382(6667):157–159. doi: 10.1126/science.adh2712
- Di Fusco M, Marczell K, Deger KA, et al. Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. J Med Econ. 2022;25(1):605–617.
- Cooper I, Mondal A, Antonopoulos CG. A SIR model assumption for the spread of COVID-19 in different communities. Chaos, Solitons & Fractals. 2020 Oct;139:110057. doi: 10.1016/j.chaos.2020.110057
- Amaro JE, Dudouet J, Orce JN. Global analysis of the COVID-19 pandemic using simple epidemiological models. Appl Math Modell. 2021;90:995–1008. doi: 10.1016/j.apm.2020.10.019
- Calafiore GC, Novara C, Possieri C. A time-varying SIRD model for the COVID-19 contagion in Italy. Annu Rev Control. 2020;50:361–372. doi: 10.1016/j.arcontrol.2020.10.005
- Ndaïrou F, Area I, Nieto JJ, et al. Mathematical modeling of COVID-19 transmission dynamics with a case study of Wuhan. Chaos, Solitons & Fractals. 2020;135:109846. doi: 10.1016/j.chaos.2020.109846
- Singapore department of statistics. Singapore residents by single year of age and sex, at End June 2022 [updated Sep 27, 2022]. Available from: https://tablebuilder.singstat.gov.sg/table/TS/M810731
- Ministry of Health Singapore. National population health survey 2020 (household interview and health examination) 2020 [Apr 4, 2023]. Available from: https://www.hpb.gov.sg/docs/default-source/default-document-library/nphs-2020-survey-report3d885bcf2c4f45fa9b6c0fde298ac688.pdf
- Yang K, Ng T, Kwang Y, et al. Prevalence of childhood asthma and control in children assessed in a pilot school‐based intervention programme in Singapore. J Paediatr Child Health. 2007;43(5):353–358.
- Picco L, Subramaniam M, Abdin E, et al. Prevalence and correlates of heart disease among adults in Singapore. Asian J Psychiatr. 2016;19:37–43. doi: 10.1016/j.ajp.2015.12.005
- George PP, Heng BH, Lim TK, et al. Evaluation of a disease management program for COPD using propensity matched control group. J Thoracic Dis. 2016;8(7):1661.
- World cancer Research fund International. Global cancer data by country 2022 [Apr 4, 2023]. Available from: https://www.wcrf.org/cancer-trends/global-cancer-data-by-country/
- Ministry of Health Singapore. COVID-19 statistics 2023 [updated February 13, 2023;September 2023]. Available from: https://www.moh.gov.sg/covid-19/statistics
- He G, Zhu S, Fu D, et al. Association between COVID-19 vaccination coverage and case fatality ratio: a comparative study—Hong Kong SAR. Chin CDC Weekly. 2022;4(30):649. China and Singapore, December 2021–March 2022.
- Tartof SY, Slezak JM, Puzniak L, et al. BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA. 4 and BA. 5. Lancet Infect Dis. 2022;22(12):1663–1665.
- Tartof SY, Slezak JM, Puzniak L, et al. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study. Lancet Respir Med. 2022;10(7):689–699.
- Arbel R, Peretz A, Sergienko R, et al. Effectiveness of the bivalent mRNA vaccine in preventing severe COVID-19 outcomes: an observational cohort study. Available at SSRN 4314067. 2023.
- Link-Gelles R. Early estimates of bivalent mRNA booster dose vaccine effectiveness in preventing symptomatic SARS-CoV-2 infection attributable to Omicron BA. 5–and XBB/XBB. 1.5–related sublineages among immunocompetent adults—increasing community access to testing program. MMWR Morb Mortal Wkly Rep. 2023;72: United States, December 2022–January 2023.
- Surie D, Bonnell L, Adams K, et al. Effectiveness of monovalent mRNA vaccines against COVID-19–associated hospitalization among immunocompetent adults during BA.1/BA.2 and BA.4/BA.5 predominant periods of SARS-CoV-2 Omicron variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(42):1327–1334. December 26, 2021–August 31, 2022. doi: 10.15585/mmwr.mm7142a3
- Surie D. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged≥ 65 years—IVY Network, 18 States, September 8–November 30, 2022. MMWR Morb Mortal Wkly Rep. 2022;71.
- Centers for Disease Control and Prevention. What is COVID-19 reinfection? 2022 [updated March 15, 2023;October 30, 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html
- Eythorsson E, Runolfsdottir HL, Ingvarsson RF, et al. Rate of SARS-CoV-2 reinfection during an omicron wave in Iceland. JAMA Netw Open. 2022;5(8):e2225320–e2225320.
- Ngiam JN, Chew N, Tham SM, et al. Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease. Inter J Infect Dis. 2021;103:329–335. doi: 10.1016/j.ijid.2020.11.157
- Ministry of Health Singapore. Update on Local COVID-19 Situation 2021 [Aug 22, 2023]. Available from: https://www.moh.gov.sg/news-highlights/details/update-on-local-covid-19-situation_6_December_2021
- Mattey‐Mora PP, Begle CA, Owusu CK, et al. Hospitalised versus outpatient COVID‐19 patients’ background characteristics and comorbidities: a systematic review and meta‐analysis. Rev Med Virol. 2022;32(3):e2306.
- Sim BLH, Chidambaram SK, Wong XC, et al. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: a nationwide observational study. Lancet Reg Health-West Pac. 2020;4:100055. doi: 10.1016/j.lanwpc.2020.100055
- Surendra H, Elyazar IR, Djaafara BA, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. Lancet Reg Health-West Pac. 2021;9:100108. doi: 10.1016/j.lanwpc.2021.100108
- Menges D, Ballouz T, Anagnostopoulos A, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. 2021;16(7):e0254523.
- Hause AM, Baggs J, Marquez P, et al. Safety monitoring of COVID-19 vaccine booster doses among adults — United States, September 22, 2021–February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):249–254. doi: 10.15585/mmwr.mm7107e1
- Klein NP. Rapid cycle analysis to monitor the safety of COVID-19 vaccines in near real-time within the vaccine safety datalink: myocarditis and anaphylaxis. ACIP meeting COVID-19 Vaccines. 2021 Aug 30;2021.
- Forbes. 1 SGD to USD: convert Singapore dollar to United States dollar 2023 [Aug 23, 2023]. Available from: https://www.forbes.com/advisor/money-transfer/currency-converter/sgd-usd/
- Wong A Covid-19 tests in Singapore: its cost and where to go 2020 [cited 2023 Mar 29, 2023]. Available from: https://www.asiaone.com/lifestyle/covid-19-tests-singapore-its-cost-and-where-go
- Singapore Medical. Medical costs guideline: online directory by Singapore medical [Mar 28, 2023]. Available from: https://singapore-medical.com/medical-costs
- Watsons Singapore. Top product catergories [Apr 5, 2023]. Available from: https://www.watsons.com.sg/product-categories/c/1
- Cai Y, Kwek S, Tang S, et al. Impact of the COVID-19 pandemic on a tertiary care public hospital in Singapore: resources and economic costs. J Hosp Infect. 2022;121:1–8. doi: 10.1016/j.jhin.2021.12.007
- Tan Tock Seng Hospital. Inpatient Charges 2021 [updated February 2023;March 31, 2023]. Available from: https://www.ttsh.com.sg/Patients-and-Visitors/Your-Hospital-Stay/Pages/Inpatient-Charges.aspx
- Chew SY, Lee YS, Ghimiray D, et al. Characteristics and outcomes of COVID-19 patients with respiratory failure admitted to a“pandemic ready” intensive care unit-lessons from Singapore. Ann Acad Med Singap. 2020;49(7):434–448.
- Agency for Healthcare Research and quality. Healthcare cost and utilization project (HCUP) [Dec 13, 2022]. Available from: https://www.hcup-us.ahrq.gov/.
- Ministry of Manpower. Labour Force in Singapore 2022 2023 [updated January 31, 2023;March 29, 2023]. Available from: https://stats.mom.gov.sg/Pages/Labour-Force-In-Singapore-2022.aspx
- Saad L, Hickman A Majority of U.S. Workers Continue To Punch In Virtually 2021 [updated 12 Feb 2021]. Available from: https://news.gallup.com/poll/329501/majority-workers-continue-punch-virtually.aspx
- Rahman R Guide to home quarantine for positive COVID-19 patients in Malaysia 2023. Available from: https://www.homage.com.my/resources/home-quarantine-covid-19-positive/
- Centers for Disease Control and Prevention. Ending isolation and precautions for people with COVID-19: interim guidance 2022 [updated 31 Aug 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html
- Agency for Care Effectiveness. Drug and vaccine evaluation methods and process guide 2021 [updated Jun 2021]. Available from: https://www.ace-hta.gov.sg/docs/default-source/process-methods/ace-methods-and-process-guide-for-drug-and-vaccine-evaluation-(28-june-2021).pdf
- Thye A-K, Tan L-H, Law JWF, et al. COVID-19 booster vaccines administration in different countries. Prog Microbes Mol Biol. 2021;4(1). doi: 10.36877/pmmb.a0000256
- Orimo H, Ito H, Suzuki T, et al. Reviewing the definition of “elderly”. Geriatrics Gerontology Int. 2006;6(3):149–158.
- United Nations Economic and Social Commission for Asia and the Pacific. Social development and ageing societies. Available from: https://www.unescap.org/our-work/social-development/ageing-societies#:~:text=Older%20persons%2C%20defined%20as%20those,be%2060%20years%20or%20over.
- Thakkar K, Spinardi J, Kyaw MH, et al. Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia. Expert Rev Vaccines. 2023;22(1):714–725.
- Thakkar K, Spinardi J, Kyaw MH, et al. Modelling the potential public health impact of different vaccination strategies with an Omicron-adapted bivalent vaccine in Thailand. Expert Rev Vaccines. 2023;22(1):860–870.
- Xu Z, Zhang H, Huang Z. A continuous Markov-chain model for the simulation of COVID-19 epidemic dynamics. Biology. 2022;11(2):190. doi: 10.3390/biology11020190
- Dehghan Shabani Z, Shahnazi R. Spatial distribution dynamics and prediction of COVID‐19 in Asian countries: spatial Markov chain approach. Region Sci Policy Practice. 2020;12(6):1005–1025. doi: 10.1111/rsp3.12372
- Lochen A, Anderson RM. Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clin Microbiol Infect. 2021 Oct;27(10):1546–1557. doi: 10.1016/j.cmi.2021.07.002